acut
fibrin
organis
pneumonia
afop
appear
variant
acut
lung
injuri
ali
characterist
diffus
alveolar
damag
dad
well
featur
organis
pneumonia
op
histopatholog
pattern
characteris
intraalveolar
fibrin
associ
mononuclear
cell
infiltr
loos
intralumin
connect
tissu
patchi
distribut
afop
lack
hyalin
membran
classic
seen
subacut
phase
dad
intrabronchiolar
fibrosi
seen
op
promin
infiltr
eosinophil
seen
eosinophil
pneumonia
afop
link
variou
condit
includ
infect
drug
toxic
occup
exposur
lung
transplant
recipi
high
risk
infect
lung
allograft
reject
signific
barrier
longterm
surviv
follow
lung
transplant
suscept
chronic
lung
allograft
dysfunct
clad
predomin
caus
oblit
bronchiol
ob
lead
bronchiol
obliteran
syndrom
bo
bo
characteris
airflow
obstruct
usual
progress
time
lead
caus
allograft
loss
recipi
death
howev
allograft
patholog
bosob
also
report
caus
clad
includ
restrict
allograft
syndrom
ra
associ
dad
precursor
lesion
lead
restrict
pattern
allograft
dysfunct
prognosi
wors
clad
caus
bo
recent
paraskeva
et
al
identifi
recipi
cohort
bilater
lung
transplant
recipi
develop
clad
patient
restrict
pattern
allograft
dysfunct
found
afop
histopatholog
radiograph
criteria
recipi
develop
afop
significantli
wors
posttranspl
surviv
cohort
recipi
develop
bosob
report
lung
transplant
recipi
develop
sever
clad
associ
afop
histopatholog
pattern
lung
biopsi
andor
autopsi
specimen
investig
approv
univers
wisconsin
human
subject
committe
approv
number
cohort
consist
total
lung
transplant
recipi
recipi
diagnos
clad
due
afop
clinic
demograph
characterist
patient
given
tabl
pertin
data
diagnost
bronchoscopi
bal
histopatholog
find
given
tabl
one
patient
case
diagnosi
made
via
surgic
lung
biopsi
figur
repeat
wedg
biopsi
patient
month
later
show
evid
persist
afop
promin
polymorphonuclear
leukocyt
infiltr
fibrin
deposit
organis
pneumonia
like
due
bacteri
infect
also
seen
second
biopsi
patient
adequ
tissu
sampl
tbb
allow
diagnosi
made
premortem
diagnosi
afop
made
autopsi
case
femal
receiv
heartlung
transplant
congenit
heart
diseas
earli
sputum
cultur
demonstr
gramneg
rod
piperacillintazobactam
given
extub
second
day
posttranspl
commenc
ambul
howev
small
bowel
complic
develop
requir
surgic
resect
develop
dialysisdepend
acut
renal
insuffici
intub
mechan
ventil
requir
day
chest
imag
show
persist
diffus
infiltr
figur
b
tbb
show
minim
acut
reject
grade
extub
day
later
requir
reintub
posttranspl
day
progress
respiratori
failur
tbb
biopsi
show
afop
show
acut
reject
figur
b
endomyocardi
biopsi
neg
cardiac
reject
laparotomi
right
hemicolectomi
perform
persist
volvulu
posttranspl
day
lung
function
worsen
citrobact
freundii
isol
blood
cultur
bal
urin
cultur
respiratori
statu
progress
worsen
life
support
withdrawn
man
receiv
success
bilater
lung
transplant
endstag
cystic
fibrosi
requir
stent
placement
right
main
bronchial
stenosi
anastomosi
site
develop
cough
dyspnoea
fever
month
posttransplant
sputum
cultur
demonstr
mucoid
pseudomona
aeruginosa
piperacillintazobactam
administ
tbb
show
minim
acut
reject
grade
cough
dyspnoea
persist
patient
resum
use
supplement
home
oxygen
acut
decompens
week
later
diffus
infiltr
thorac
imag
figur
c
develop
shock
respiratori
insuffici
requir
intens
care
unit
admiss
administr
pressor
tracheal
intub
mechan
ventil
group
streptococcu
pyogen
present
multipl
blood
cultur
diabet
ketoacidosi
also
present
success
treat
extub
discharg
home
day
admiss
period
clinic
stabil
develop
sustain
declin
forc
expiratori
volum
second
bal
show
methicillinsensit
staphylococcu
aureu
mssa
mucoid
p
aeruginosa
tbb
show
acut
reject
specif
parenchym
abnorm
antibiot
administ
blood
cultur
grew
candida
albican
stenotrophomona
maltophilia
intub
mechan
ventilatori
support
requir
due
lack
improv
appropri
antibacteri
antifung
therapi
surgic
lung
biopsi
perform
show
afop
figur
c
chest
imag
show
persist
infiltr
care
withdrawn
month
mechan
ventil
femal
receiv
left
singl
lung
transplant
fibrot
nonspecif
interstiti
pneumonia
nsip
week
posttranspl
surveil
tbb
specimen
show
grade
acut
reject
tbb
perform
week
later
show
grade
acut
reject
intraven
methylprednisolon
burst
taper
given
remain
asymptomat
continu
improv
clinic
week
posttranspl
present
increas
dyspnoea
exert
cough
lowgrad
fever
progress
intub
mechan
ventil
treat
broadspectrum
antibacteri
agent
puls
corticosteroid
tbb
demonstr
organis
pneumonia
op
acut
reject
bal
reveal
pathogen
success
extub
day
wean
room
air
discharg
home
howev
subsequ
surveil
tbb
show
persist
op
well
acut
reject
grade
total
lymphoid
irradi
initi
patient
readmit
week
later
short
breath
hypoxaemia
progress
respiratori
failur
requir
mechan
ventil
despit
broadspectrum
antibiot
puls
corticosteroid
diffus
parenchym
opac
figur
progress
worsen
support
care
eventu
withdrawn
afop
observ
lung
specimen
examin
autopsi
figur
e
f
woman
consid
cure
hodgkin
lymphoma
underw
bilater
lung
transplant
bleomycinassoci
pulmonari
fibrosi
benign
clinic
cours
next
year
despit
persist
poor
graft
function
diagnos
left
breast
ductal
carcinoma
underw
mastectomi
start
tamoxifen
three
month
later
note
persist
mild
symptom
cough
dyspnoea
exert
associ
new
persist
infiltr
imag
figur
e
f
accompani
signific
declin
oxyhaemoglobin
desatur
activ
tbb
reveal
afop
highdos
corticosteroid
broadspectrum
antibiot
given
bal
detect
multidrug
resist
maltophilia
antibacteri
coverag
adjust
gradual
improv
discharg
home
stabl
period
month
develop
increas
short
breath
thorac
hrct
show
multipl
new
lung
nodul
lung
biopsi
reveal
metastat
breast
cancer
succumb
month
later
femal
receiv
right
singl
lung
transplant
idiopath
pulmonari
fibrosi
uncompl
posttranspl
cours
surveil
bronchoscopi
show
acut
reject
infect
month
posttransplant
reach
zenith
predict
remain
stabl
next
month
diagnos
bo
stage
chest
imag
reveal
new
patchi
consolid
allograft
bronchoscopi
reveal
bal
neutrophilia
cytomegaloviru
detect
bal
peripher
blood
via
polymeras
chain
reaction
tbb
neg
acut
reject
cytomegaloviru
pneumon
show
chang
afop
intraven
puls
methylprednisolon
antibiot
administ
gradual
clear
allograft
infiltr
cxr
howev
continu
declin
followup
bronchoscopi
month
later
reveal
persist
afop
bal
neutrophilia
despit
clear
allograft
infiltr
cxr
bal
neg
infect
subsequ
progress
declin
patient
eventu
succumb
respiratori
failur
male
receiv
bilater
lung
transplant
cystic
fibrosi
essenti
uncompl
posttransplant
cours
month
except
grade
reject
episod
month
posttranspl
develop
worsen
cough
increas
fatigu
dyspnoea
follow
exposur
spous
develop
upper
respiratori
tract
infect
symptom
spirometri
show
signific
declin
oxyhaemoglobin
desatur
note
tbb
reveal
chang
afop
also
grade
show
grade
acut
reject
bal
cultur
mssa
coloni
form
unit
cfu
neg
respiratori
virus
patient
symptom
initi
improv
antibiot
puls
methylprednisolon
subsequ
progress
declin
patient
eventu
succumb
respiratori
insuffici
beasley
colleagu
describ
afop
new
histopatholog
entiti
conclud
repres
unusu
variant
ali
op
characteris
bud
granul
tissu
compris
fibroblast
myofibroblast
matrix
loos
connect
tissu
distal
airspac
alveolar
duct
alveoli
bronchiol
may
idiopath
cryptogen
organis
pneumonia
cop
op
associ
varieti
clinic
entiti
infect
connect
tissu
disord
pneumotox
drug
reaction
dad
also
associ
number
clinic
disord
infect
drug
toxic
characteris
alveolar
epitheli
cell
endotheli
injuri
fluid
cellular
exud
follow
repar
fibroblast
prolifer
alveolar
type
ii
pneumocyt
hyperplasia
hyalin
membran
format
mark
exud
phase
dad
afop
characteris
histopatholog
intraalveolar
fibrin
form
fibrin
ball
within
alveolar
space
presenc
fibrin
ball
differenti
afop
classic
op
granul
tissu
bronchiol
alveolar
duct
alveoli
well
dad
classic
hyalin
membran
patchi
distribut
fibrin
deposit
typic
involv
alveolar
space
averag
airspac
involv
overal
contrast
afop
dad
typic
diffus
although
afop
lack
classic
hyalin
membran
characteris
dad
myxoid
fibroblast
tissu
identifi
alveolar
wall
afop
dad
eosinophil
typic
present
predomin
eosinophil
pneumon
routin
chest
radiograph
patient
afop
typic
show
interstiti
chang
may
show
area
appear
consolid
patient
diffus
persist
infiltr
thorac
imag
hrct
imag
figur
show
peribronchi
perilobular
consolid
area
groundglass
opac
bronchoalveolar
lavag
perform
time
diagnosi
afop
tabl
show
consider
bal
neutrophilia
patient
patient
bacteria
visualis
gram
stain
bal
fluid
mani
clinic
condit
associ
afop
afop
link
drug
reaction
eg
decitabin
amiodaron
abacavir
infect
eg
sever
acut
respiratori
syndrom
respiratori
syncyti
viru
haemophilu
influenza
acinetobact
variou
form
connect
tissu
disord
associ
includ
stem
cell
transplant
haematolog
malign
occup
exposur
cigarett
smoke
although
afop
often
run
rapid
fatal
cours
respons
pharmacolog
intervent
report
treatment
associ
signific
clinic
respons
includ
corticosteroid
cyclophosphamid
mycophenol
acut
onset
accompani
need
mechan
ventil
appear
correl
poor
prognosi
infect
andor
drug
toxic
may
play
key
role
afop
pathogenesi
patient
anoth
possibl
afop
repres
form
allograft
reject
although
patient
ongo
intens
immunosuppress
variou
complic
associ
lung
transplant
statu
patient
improv
intensifi
immun
suppress
none
subject
receiv
drug
link
afop
publish
literatur
addit
none
surgic
tbb
specimen
reveal
consist
associ
acut
reject
lymphocyt
bronchiol
intens
immunosuppress
multipl
drug
lung
transplant
recipi
receiv
plu
numer
drug
mani
associ
potenti
pulmonari
toxic
take
manag
posttranspl
issu
well
ongo
colonis
andor
infect
potenti
pathogen
difficult
associ
afop
specif
caus
patient
stabilis
appear
recov
dyspnoea
infiltr
chest
radiograph
ga
exchang
rapidli
worsen
stabilis
gradual
improv
intensifi
immunosuppress
intraven
methylprednisolon
subsequ
gradual
prednison
taper
given
point
interest
infrequ
occurr
afop
recipi
popul
compar
report
paraskeva
et
al
sato
et
al
use
declin
baselin
total
lung
capac
tlc
indic
presenc
restrict
physiolog
addit
presenc
radiograph
infiltr
chest
imag
dad
histopatholog
diagnost
ra
form
clad
although
measur
lung
volum
cohort
recipi
afop
clear
declin
along
forc
vital
capac
fvc
subject
consist
restrict
physiolog
centr
measur
lung
volum
mani
factor
confound
measur
tlc
suggest
combin
spirometri
imag
find
histopatholog
use
identifi
afop
differenti
ra
classic
obstruct
bosob
phenotyp
clad
experi
plu
report
paraskeva
et
al
indic
afop
consid
diagnosi
transplant
recipi
develop
allograft
dysfunct
clinic
evalu
suggest
clad
associ
restrict
physiolog
radiograph
infiltr
develop
although
upper
lobe
infiltr
set
highli
suggest
diagnosi
ra
lung
biopsi
requir
differenti
afop
ra
conclus
identifi
lung
transplant
recipi
develop
diffus
infiltr
histopatholog
chang
afop
lung
tissu
specimen
indic
afop
associ
lung
function
declin
follow
transplant
although
afop
associ
number
incit
factor
nontranspl
patient
could
definit
link
specif
caus
declin
lung
allograft
function
diagnosi
afop
patient
howev
recipi
seriou
infecti
complic
andor
episod
allograft
reject
prior
onset
afop
conclud
histopatholog
chang
consist
afop
bet
associ
persist
posttranspl
declin
allograft
function
recipi
develop
afop
may
meet
criteria
consist
diagnosi
clad
clinic
characterist
overlap
ra
subset
clad
infiltr
hrct
declin
fvc
consist
ventilatori
restrict
occur
infrequ
appear
associ
poor
prognosi
characteris
afop
phenotyp
clad
may
assist
effort
prevent
andor
treat
potenti
complic
lung
transplant
